The class II histone deacetylases as therapeutic targets for Parkinson’s disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterised by specific motor impairments. The neuropathological hallmarks of PD include progressive degeneration of midbrain dopaminergic neurons, and loss of their axonal projections to the striatum. Additionally, there is prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzocchi, Martina, Collins, Louise M, Sullivan, Aideen M., O'Keeffe, Gerard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373248/
https://www.ncbi.nlm.nih.gov/pubmed/32714601
http://dx.doi.org/10.1042/NS20200001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373248/
https://www.ncbi.nlm.nih.gov/pubmed/32714601
http://dx.doi.org/10.1042/NS20200001

Ejemplares similares